Asset Details
Do you wish to reserve the book?
A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma
Do you wish to request the book?
A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma
2022
Overview
Background
DNA polymerase delta 1 catalytic subunit (POLD1) plays a key role in DNA replication and damage repair. A defective DNA proofreading function caused by POLD1 mutation contributes to carcinogenesis, while POLD1 overexpression predicts poor prognosis in cancers. However, the effect of POLD1 in hepatocellular carcinoma (HCC) is not well-understood.
Methods
Expression patterns of POLD1 were evaluated in TCGA and the HPA databases. Kaplan-Meier curves and Cox regression were used to examine the prognostic value of POLD1. The prognostic and predictive value of POLD1 was further validated by another independent cohort from ICGC database. The influences of DNA copy number variation, methylation and miRNA on POLD1 mRNA expression were examined. The correlation between infiltrating immune cells and POLD1 expression was analyzed. GO and KEGG enrichment analyses were performed to detect biological pathways associated with POLD1 expression in HCC.
Results
POLD1 was overexpressed in HCC (
n
= 369) compared with adjacent normal liver (
n
= 50). POLD1 upregulation was significantly correlated with positive serum AFP and advanced TNM stage. Kaplan–Meier and multivariate analyses suggested that POLD1 overexpression predicts poor prognosis in HCC. DNA copy gain, low POLD1 methylation, and miR‑139-3p downregulation were associated with POLD1 overexpression. Besides, POLD1 expression was associated with the infiltration levels of dendritic cell, macrophage, B cell, and CD4 + T cell in HCC. Functional enrichment analysis suggested “DNA replication”, “mismatch repair” and “cell cycle” pathways might be involved in the effect of POLD1 on HCC pathogenesis. Additionally, POLD1 mRNA expression was significantly associated with tumor mutation burden, microsatellite instability, and prognosis in various tumors.
Conclusions
POLD1 may be a potential prognostic marker and promising therapeutic target in HCC.
Publisher
BioMed Central,BioMed Central Ltd,BMC
Subject
/ Biomarkers, Tumor - genetics
/ Biomedical and Life Sciences
/ Cancer
/ Carcinoma, Hepatocellular - genetics
/ Carcinoma, Hepatocellular - mortality
/ DNA Copy Number Variations - genetics
/ DNA Polymerase III - metabolism
/ Female
/ Health Promotion and Disease Prevention
/ Hepatoma
/ Humans
/ Lymphocytes, Tumor-Infiltrating - metabolism
/ Male
/ Oncology
/ POLD1
